Stronger warnings for organ-rejection immunosuppressants
This article was originally published in Scrip
Executive Summary
Makers of some immunosuppressants that are used in kidney transplants will update their products' labels to highlight the risk of opportunistic infections, especially BK virus associated nephropathy, following US FDA guidance.